Halliburton Labs has announced the addition of three clean energy tech companies. Photo courtesy of Halliburton

Halliburton has again added a handful of energy tech startups to its Houston-based incubator.

Three companies — Matrix Sensors, Renew Power Systems, and SunGreenH2 — have joined Halliburton Labs as its newest clean energy participants.

“Companies across the energy landscape are interested in scalable innovations that improve the cost, reliability, and sustainability of energy,” says Managing Director Dale Winger in the news release. “Our tailored program combines expert support, access to a global network, and the physical resources for participants to scale. We’re excited to help these companies accelerate their market traction.”

Halliburton, a provider of energy equipment and services, launched Halliburton Labs in 2020. Last September was the incubator's last cohort addition. The next Halliburton Labs Finalists Pitch Day is Friday, January 27, at the Ion. The event will include pitches from 10 innovative, early-stage energy tech companies. Registration is open for the event.

Here are details, according to Halliburton, about the three new startups at the incubator.

Matrix Sensors

Using a new class of gas-adsorbing materials known as metal-organic frameworks to develop the world’s first quantitative gas sensor on a chip, Matrix Sensors has created a touch-free technology that enables advancements in sensor size, power, cost, and performance to address limitations of current gas sensor technologies, which require manual calibration every six months. The company is based in San Diego, California.

“With Halliburton’s global reach, we can apply our technology to some of the biggest problems facing the energy sector today, including CO2 sensors for energy efficient buildings and methane sensors for leak detection,” says Matrix Sensors CEO Steve Yamamoto in the release.

Renew Power Systems

RPSi, based in Minneapolis, Minnesota, is a clean-tech company that develops hardware and software solutions that enable flexible and sustainable grid infrastructure. RPSi uses power electronics to connect renewable energy resources, such as wind and solar, with each other and the grid.

“Our mission is to help change the way the world generates and distributes energy,” says CEO Zach Emond in the release. “With RPSi technology, a diverse range of domestic and global communities will benefit from the acceleration of renewable energy resources that work with new and existing grid infrastructure and improve access to affordable, sustainable, and resilient electricity.”

SunGreenH2

Singapore-based SunGreenH2 builds high-performance hardware for electrolyzer cells, stacks, and systems that increase hydrogen production, decrease energy use, and reduce platinum group metals use. The company supplies hardware components for alkaline and proton-exchange membrane electrolyzers. Its modular, high-efficiency anion exchange membrane (AEM) electrolyzer stack, which is being commercialized, uses renewable power to produce low-cost green hydrogen for industries, transport, and energy storage.

“We are excited to unlock the future of green hydrogen production. With the help of Halliburton’s engineering and manufacturing expertise, we plan to commercialize and roll out our product in major international markets,” says Tulika Raj, co-founder and CEO of the company, in the release.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Rice University lands $18M to revolutionize lymphatic disease detection

fresh funding

An arm of the U.S. Department of Health and Human Services has awarded $18 million to scientists at Rice University for research that has the potential to revolutionize how lymphatic diseases are detected and help increase survivability.

The lymphatic system is the network of vessels all over the body that help eliminate waste, absorb fat and maintain fluid balance. Diseases in this system are often difficult to detect early due to the small size of the vessels and the invasiveness of biopsy testing. Though survival rates of lymph disease have skyrocketed in the United States over the last five years, it still claims around 200,000 people in the country annually.

Early detection of complex lymphatic anomalies (CLAs) and lymphedema is essential in increasing successful treatment rates. That’s where Rice University’s SynthX Center, directed by Han Xiao and Lei Li, an assistant professor of electrical and computer engineering, comes in.

Aided by researchers from Texas Children’s Hospital, Baylor College of Medicine, the University of Texas at Dallas and the University of Texas Southwestern Medical Center, the center is pioneering two technologies: the Visual Imaging System for Tracing and Analyzing Lymphatics with Photoacoustics (VISTA-LYMPH) and Digital Plasmonic Nanobubble Detection for Protein (DIAMOND-P).

Simply put, VISTA-LYMPH uses photoacoustic tomography (PAT), a combination of light and sound, to more accurately map the tiny vessels of the lymphatic system. The process is more effective than diagnostic tools that use only light or sound, independent of one another. The research award is through the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program, part of the U.S. HHS, which saw the potential of VISTA-LYMPH in animal tests that produced finely detailed diagnostic maps.

“Thanks to ARPA-H’s award, we will build the most advanced PAT system to image the body’s lymphatic network with unprecedented resolution and speed, enabling earlier and more accurate diagnosis,” Li said in a news release.

Meanwhile, DIAMOND-P could replace the older, less exact immunoassay. It uses laser-heated vapors of plasmonic nanoparticles to detect viruses without having to separate or amplify, and at room temperature, greatly simplifying the process. This is an important part of greater diagnosis because even with VISTA-LYMPH’s greater imaging accuracy, many lymphatic diseases still do not appear. Detecting biological markers is still necessary.

According to Rice, the efforts will help address lymphatic disorders, including Gorham-Stout disease, kaposiform lymphangiomatosis and generalized lymphatic anomaly. They also could help manage conditions associated with lymphatic dysfunction, including cancer metastasis, cardiovascular disease and neurodegeneration.

“By validating VISTA-LYMPH and DIAMOND-P in both preclinical and clinical settings, the team aims to establish a comprehensive diagnostic pipeline for lymphatic diseases and potentially beyond,” Xiao added in the release.

The ARPA-H award funds the project for up to five years.

Houston doctor wins NIH grant to test virtual reality for ICU delirium

Virtual healing

Think of it like a reverse version of The Matrix. A person wakes up in a hospital bed and gets plugged into a virtual reality game world in order to heal.

While it may sound far-fetched, Dr. Hina Faisal, a Houston Methodist critical care specialist in the Department of Surgery, was recently awarded a $242,000 grant from the National Institute of Health to test the effects of VR games on patients coming out of major surgery in the intensive care unit (ICU).

The five-year study will focus on older patients using mental stimulation techniques to reduce incidences of delirium. The award comes courtesy of the National Institute on Aging K76 Paul B. Beeson Emerging Leaders Career Development Award in Aging.

“As the population of older adults continues to grow, the need for effective, scalable interventions to prevent postoperative complications like delirium is more important than ever,” Faisal said in a news release.

ICU delirium is a serious condition that can lead to major complications and even death. Roughly 87 percent of patients who undergo major surgery involving intubation will experience some form of delirium coming out of anesthesia. Causes can range from infection to drug reactions. While many cases are mild, prolonged ICU delirium may prevent a patient from following medical advice or even cause them to hurt themselves.

Using VR games to treat delirium is a rapidly emerging and exciting branch of medicine. Studies show that VR games can help promote mental activity, memory and cognitive function. However, the full benefits are currently unknown as studies have been hampered by small patient populations.

Faisal believes that half of all ICU delirium cases are preventable through VR treatment. Currently, a general lack of knowledge and resources has been holding back the advancement of the treatment.

Hopefully, the work of Faisal in one of the busiest medical cities in the world can alleviate that problem as she spends the next half-decade plugging patients into games to aid in their healing.